VOLORIDGE INVESTMENT MANAGEMENT, LLC - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.

Quarter-by-quarter ownership
VOLORIDGE INVESTMENT MANAGEMENT, LLC ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$1,336,313
+2.8%
245,195
+26.6%
0.01%
+16.7%
Q2 2023$1,299,948
-56.3%
193,733
-42.4%
0.01%
-60.0%
Q1 2023$2,971,887
-4.6%
336,567
-17.4%
0.02%
-11.8%
Q4 2022$3,114,324
+45.0%
407,634
+35.1%
0.02%
+41.7%
Q3 2022$2,148,000
+23.4%
301,754
+40.2%
0.01%
+33.3%
Q2 2022$1,741,000
+48.5%
215,258
+154.9%
0.01%
+28.6%
Q1 2022$1,172,000
+32.3%
84,456
+167.3%
0.01%
+40.0%
Q4 2021$886,000
+266.1%
31,593
+343.8%
0.01%
+150.0%
Q3 2021$242,000
-94.5%
7,118
-93.4%
0.00%
-93.5%
Q2 2021$4,412,000
-18.1%
107,977
-19.3%
0.03%
-20.5%
Q1 2021$5,387,000
-59.2%
133,794
-40.1%
0.04%
-64.9%
Q4 2020$13,206,000
+172.9%
223,339
+124.5%
0.11%
+177.5%
Q3 2020$4,839,000
+356.5%
99,503
+354.4%
0.04%
+233.3%
Q2 2020$1,060,00021,9000.01%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q2 2022
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 3,030,434$23,152,51615.55%
BERYLSON CAPITAL PARTNERS, LLC 289,726$2,213,5076.45%
Matrix Capital Management Company, LP 11,572,590$88,414,5881.69%
Pier Capital, LLC 1,012,401$7,734,7441.27%
VIKING GLOBAL INVESTORS LP 29,993,708$229,151,9291.15%
Eagle Health Investments LP 607,860$4,644,0501.07%
Triatomic Management LP 130,805$999,3500.84%
Aristotle Atlantic Partners, LLC 1,880,567$14,367,5320.80%
Senator Investment Group LP 1,000,000$7,640,0000.69%
ARK Investment Management 9,201,245$70,297,5120.61%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders